U.S. Markets for Drug and Fluid Delivery Devices
U.S. Markets for Drug and Fluid Delivery Devices
$5,250.00
Pharmacotherapy represents the first-line treatment in the management of most chronic and transient medical conditions warranting therapeutic intervention in the U.S.
Publisher: Medtech Insight
- Description
- Contents
- Samples
Pharmacotherapy represents the first-line treatment in the management of most chronic and transient medical conditions warranting therapeutic intervention in the U.S. To date, more than 40,000 prescription drug products containing 2,700 active ingredients have been approved by the FDA; these products accounted for more than 70% of the national pharmaceutical usage in 2014. In the same year, U.S. pharmacies processed nearly 4 billion prescriptions, generating more than $310.0 billion in cumulative pharmaceutical sales and representing nearly 13% of the nation’s total healthcare spending. This report covers injection/infusion, transdermal, and inhalation drug delivery devices.
This new report by Medtech Insight presents a detailed overview of the U.S. drug and fluid delivery devices market. Major topics covered by this report include an overview of drug delivery technologies, injection/infusion drug delivery systems (e.g., syringes, injection pens, needleless jet injectors, infusion pumps and disposables, gravity infusion systems, and vascular access devices), transdermal drug delivery systems (e.g., patch-based pharmaceutical products for cardiovascular disease management, central nervous system disorder management, hormone replacement therapy, acute and chronic pain management, and urologic disorder management), and inhalation drug delivery systems (e.g., inhaled insulin delivery systems and inhaled respiratory drug systems such as dry powder inhaler- and metered dose inhaler-based preparations for the treatment of asthma, chronic obstructive pulmonary disease, and cystic fibrosis).
Table of Contents
EXECUTIVE SUMMARY
…………………………………………………………………………. ES-1
i. Injection/Infusion Drug Delivery Systems ………………………………… ES-1
ii. Transdermal Drug Delivery Systems ………………………………………. ES-4
iii. Inhalation Drug Delivery Systems…………………………………………… ES-6
iv. Methodology
……………………………………………………………………….. ES-9
Exhibit ES-1: Injection/Infusion Drug Delivery Systems, Market Share,
by Product Segment, 2014 and 2019 ……………………………………… ES-3
Exhibit ES-2: Patch-Based Pharmaceutical Products, Market Share,
by Product Segment, 2014 and 2019 ……………………………………… ES-7
Exhibit ES-3: Inhalation Drug Delivery Products, Market Share,
by Product Segment, 2014 and 2019 ……………………………………. ES-10
1. INJECTION/INFUSION DRUG DELIVERY SYSTEMS …………………………. 1-1
1.1 Products and Technologies ………………………………………………………
1-1
1.2.1 Syringe Products ……………………………………………………… 1-2
1.2.1.1 Multipurpose Standard Syringes ………………….. 1-5
1.2.1.2 Multipurpose Safety Syringes………………………. 1-5
1.2.1.3 Insulin Syringes …………………………………………. 1-7
1.2.1.4 Market Analysis …………………………………………. 1-8
1.2.1.5 Competitive Analysis ………………………………….. 1-8
1.2.2 Injection Pen Products ……………………………………………. 1-11
1.2.2.1 Market Analysis ……………………………………….. 1-13
1.2.2.2 Competitive Analysis ………………………………… 1-13
1.2.3 Needleless Jet Injector Products ………………………………. 1-16
1.2.3.1 Market Analysis ……………………………………….. 1-18
1.2.3.2 Competitive Analysis ………………………………… 1-18
1.2.4 Infusion Pump Products ………………………………………….. 1-21
1.2.4.1 Volumetric Pumps ……………………………………. 1-23
1.2.4.1.1 Market Analysis…………………….. 1-26
1.2.4.1.2 Competitive Analysis……………… 1-30
1.2.4.2 Syringe Pumps ………………………………………… 1-30
1.2.4.2.1 Market Analysis…………………….. 1-32
1.2.4.2.2 Competitive Analysis……………… 1-33
1.2.4.3 Ambulatory Pumps …………………………………… 1-33
1.2.4.3.1 Market Analysis…………………….. 1-37
1.2.4.3.2 Competitive Analysis……………… 1-38
Exhibit ES-1: Injection/Infusion Drug Delivery Systems, Market Share,
by Product Segment, 2014 and 2019
© Informa UK Ltd. This document is a licensed product and is not to be reproduced or redistributed
Do you have a subscription to Datamonitor Healthcare, Biomedtracker or Meddevicetracker? You may already have access to these reports, contact your account manager or email pharma@informabi.com for further help or assistance.
Tybost 
Sign up to the